Global Drug Screening Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

The Drug Screening Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Drug Screening Market Size and Projected Growth Rate?
In the recent past, the drug screening market has seen rapid expansion. The projected growth is from $8.57 billion in 2024 to $9.79 billion in 2025, indicating a compound annual growth rate (CAGR) of 14.2%. Factors driving this substantial growth in the historical phase include pharmaceutical drug evaluations, healthcare and clinical diagnostic applications, substance abuse treatments, investment in research and development, as well as the enhanced utilization of drug testing kits and devices.

The market size of drug screening is predicted to witness a swift expansion in the coming years, reaching $17.1 billion in 2029 with a compound annual growth rate (CAGR) of 15.0%. The anticipated expansion during the forecasted period can be credited to the legalization of cannabis* and the opioid crisis, an increase in sports events, on-the-spot and quick testing, the evolution of drug policies and regulations, the rise of workplace wellness and health initiatives, and enlargement of international markets. Leading trends for the forecast period comprise advancements in drug detection technologies, the rise of telemedicine and distant testing, backing in research and development, state-of-the-art drug testing kits and apparatuses, and technological progressions in testing.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6369

What Are the Major Segments in the Drug Screening Market?
The drug screening market covered in this report is segmented -

1) By Products: Rapid Testing Devices, Consumables, Other Products
2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types
3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:
1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips
2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards
3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

What Are The Driving Drug Screening Market Evolution?
The increase in drug and alcohol usage is anticipated to augment the expansion of the drug screening market. Drug dependency, a disease which influences a person's brain and behavioral patterns, leads to loss of control over lawful or unlawful drug or medication use. Alcohol, marijuana, and nicotine are few of the substances classified as drugs. An escalation in drug and alcohol addiction escalates the risk of diseases, thereby necessitating drug screening. For example, drug and alcohol use remained a major global issue in 2022. The National Survey on Drug Use and Health (NSDUH) revealed that 13.5% of Americans aged 12 and up consumed drugs in the previous month, showing an increase of 3.8% compared to the previous year. The report also indicated that 59.277 million people, or 21.4% of individuals aged 12 or older, have abused illegal drugs or prescription medications in the past year. The pandemic has exacerbated drug risks, with cannabis* consumption among young people surging up to four-fold in certain regions. Thus, the surge in drug and alcohol use is fuelling the growth of the drug screening market in the forthcoming period.

Which Firms Dominate The Drug Screening Market Segments?
Major companies operating in the drug screening market include Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

What Trends Are Expected to Dominate the Drug Screening Market in the Next 5 Years?
The trend of introducing groundbreaking products is gaining traction in the drug screening market. To satisfy the rapidly growing demand in the industry and fortify their market standing, leading entities in the sector are concentrated on inventing and launching state-of-the-art goods. The COVID pandemic instigated a sudden shift in drug screening techniques, leading to methodological transformations and prompting firms to innovate and develop new items. To keep up with these changes, organizations are making an effort to launch new, more effective drug tests that can be extensively utilized by labs. As an example, Sysmex Corporation, a health company based in Japan, unveiled the UF-1500 Fully Automated Urine Particle Testing Analyzer, a fresh product intended for urine sediment testing and screening, in September 2022. The UF-1500 carries forward the exceptional usability and functionality of the UF-5000 Fully Automated Urine Particle Analyzer, Sysmex's marquee model for urine sediment testing, while also downsizing the previous model.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Which Is The Largest Region In The Drug Screening Market?
North America was the largest region in the drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Drug Screening Market?
2. What is the CAGR expected in the Drug Screening Market?
3. What Are the Key Innovations Transforming the Drug Screening Industry?
4. Which Region Is Leading the Drug Screening Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.